These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36532822)

  • 1. Retrospective Study of a Sustained-Release Intracanalicular Dexamethasone Insert for Treatment of Ocular Inflammation After Cataract and Corneal Surgery.
    Fram N; Alsetri H; Shiler O; Paterno PJ; Cabang J
    Clin Ophthalmol; 2022; 16():4065-4074. PubMed ID: 36532822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sustained-release intracanalicular dexamethasone insert (Dextenza) for pediatric cataract surgery.
    Trivedi RH; Wilson ME
    J AAPOS; 2021 Feb; 25(1):43-45. PubMed ID: 33321213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone Sustained-Release Intracanalicular Insert for Control of Postoperative Inflammation After Pars Plana Vitrectomy.
    Suñer IJ; Peden MC
    Clin Ophthalmol; 2021; 15():3859-3864. PubMed ID: 34556974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized, Prospective, Observer-Masked Study Comparing Dropless Treatment Regimen Using Intracanalicular Dexamethasone Insert, Intracameral Ketorolac, and Intracameral Moxifloxacin versus Conventional Topical Therapy to Control Postoperative Pain and Inflammation in Cataract Surgery.
    Donnenfeld ED; Hovanesian JA; Malik AG; Wong A
    Clin Ophthalmol; 2023; 17():2349-2356. PubMed ID: 37600148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of topical vs intracanalicular corticosteroids for the prevention of postoperative inflammation after cataract surgery.
    Lu AQ; Rizk M; O'Rourke T; Goodling K; Lehman E; Scott IU; Pantanelli SM
    J Cataract Refract Surg; 2022 Nov; 48(11):1242-1247. PubMed ID: 35537939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized, Controlled, Prospective Study of the Effectiveness and Safety of an Intracanalicular Dexamethasone Ophthalmic Insert (0.4 Mg) for the Treatment of Post-Operative Inflammation in Patients Undergoing Refractive Lens Exchange (RLE).
    Larsen J; Whitt T; Parker B; Swan R
    Clin Ophthalmol; 2021; 15():2211-2217. PubMed ID: 34079218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Clinic Optometrist Insertion of Dextenza (Dexamethasone Ophthalmic Insert 0.4mg) Prior to Cataract Surgery: The PREPARE Study.
    Ibach MJ; Zimprich L; Wallin DD; Olevson C; Puls-Boever K; Thompson V
    Clin Ophthalmol; 2022; 16():2609-2615. PubMed ID: 35992569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone 0.4mg Sustained-Release Intracanalicular Insert in the Management of Ocular Inflammation and Pain Following Ophthalmic Surgery: Design, Development and Place in Therapy.
    Brooks CC; Jabbehdari S; Gupta PK
    Clin Ophthalmol; 2020; 14():89-94. PubMed ID: 32021072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone Intracanalicular Insert: A Review in Treating Post-Surgical Ocular Pain and Inflammation.
    Lee A; Blair HA
    Drugs; 2020 Jul; 80(11):1101-1108. PubMed ID: 32588339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Same-Day versus Next-Day Dexamethasone Intracanalicular Insert Administration for Inflammation and Pain Control Following Cataract Surgery: A Retrospective Analysis.
    Foster B
    Clin Ophthalmol; 2021; 15():4091-4096. PubMed ID: 34703199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery.
    Tyson SL; Bafna S; Gira JP; Goldberg DF; Jones JJ; Jones MP; Kim JK; Martel JM; Nordlund ML; Piovanetti-Perez IK; Singh IP; Metzinger JL; Mulani D; Sane S; Talamo JH; Goldstein MH;
    J Cataract Refract Surg; 2019 Feb; 45(2):204-212. PubMed ID: 30367938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of topical dexamethasone eye drops in preventing ocular inflammation and cystoid macular edema following uncomplicated cataract surgery with or without injection of a single dose perioperative subtenon triamcinolone acetonide.
    Karasu B; Kesim E; Kaskal M; Celebi ARC
    Cutan Ocul Toxicol; 2022 Dec; 41(4):310-317. PubMed ID: 36308286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Real-World Patient and Staff Experience with an Intracanalicular Dexamethasone Insert.
    Nijm L; Matossian C; Rhee MK; Stephens JD; Rosselson ME; Majmudar PA; Gollamudi SR; Patel RH; Bauskar A; Montieth A; Vantipalli S; Gibson A; Metzinger JL; Goldstein MH; Gurses Ozden R
    Clin Ophthalmol; 2024; 18():1391-1401. PubMed ID: 38784434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracanalicular Dexamethasone Insert or Topical Prednisolone Following iStent and Hydrus Surgery for Glaucoma.
    Jackson KJ; Akrobetu D; Guduru A; Herndon LW
    J Glaucoma; 2022 Aug; 31(8):694-699. PubMed ID: 35439795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Same-Day versus Next-Day Implantation of Intracanalicular Dexamethasone for the Control of Postoperative Inflammation and Pain Following Cataract Surgery.
    Saenz B; Ferguson TJ; Abraham N; Mueller BH; Parkhurst GD
    Clin Ophthalmol; 2021; 15():4615-4620. PubMed ID: 34916773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone Intracanalicular Insert for Clinically Significant Aqueous-Deficient Dry Eye: A Randomized Controlled Trial.
    Lin MX; Guo L; Saldanha IJ; VanCourt S; Zeng J; Karakus S; Hessen M; Li G; Akpek EK
    Ophthalmology; 2024 Mar; ():. PubMed ID: 38492864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effectiveness and Safety of Dextenza 0.4 mg for the Treatment of Postoperative Inflammation and Pain in Patients After Photorefractive Keratectomy: The RESTORE Trial.
    Ibach MJ; Shafer BM; Wallin DD; Puls-Boever KR; Thompson VM; Berdahl JP
    J Refract Surg; 2021 Sep; 37(9):590-594. PubMed ID: 34506241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracameral dexamethasone 9% vs prednisolone acetate 1% in controlling postoperative pain and inflammation in patients undergoing cataract surgery.
    Hovanesian JA; Donnenfeld ED
    J Cataract Refract Surg; 2022 Aug; 48(8):906-911. PubMed ID: 35067660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vehicle-Controlled, Phase 2 Clinical Trial of a Sustained-Release Dexamethasone Intracanalicular Insert in a Chronic Allergen Challenge Model.
    Torkildsen G; Abelson MB; Gomes PJ; McLaurin E; Potts SL; Mah FS
    J Ocul Pharmacol Ther; 2017 Mar; 33(2):79-90. PubMed ID: 28072552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DEPOT Study (Dry Eye Prescription Options for Therapy): Assessing the Efficacy and Safety of OTX-DED (Dexamethasone Ophthalmic Insert 0.3 mg) for Intracanalicular Use Compared with Loteprednol Suspension for the Treatment of Episodic Dry Eye.
    Hovanesian JA; Keyser A; Berdy G; Sorensen R
    Clin Ophthalmol; 2022; 16():3841-3849. PubMed ID: 36438591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.